Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 7/20 | 0.43 |
| ▸ | NPY4R | P50391 | 6/20 | 0.42 |
| ▸ | NPY1R | P25929 | 4/20 | 0.42 |
| ▸ | NPY2R | P49146 | 4/20 | 0.42 |
| ▸ | NPY5R | Q15761 | 4/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 3/20 | 0.42 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.41 |
| ▸ | OPRK1 | P41145 | 6/20 | 0.41 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28645300 | 1.00 | OPRM1 (0.43) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28637450 | 0.94 | OPRM1 (0.45) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28637452 | 0.94 | OPRM1 (0.45) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22117843 | 0.93 | NPY4R (0.47) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22117841 | 0.93 | NPY4R (0.47) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28638783 | 0.92 | NPY4R (0.41) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28638778 | 0.92 | NPY4R (0.41) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28652449 | 0.88 | NPY4R (0.46) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL28652444 | 0.88 | NPY4R (0.46) | OPRM1NPY4RNPY1RNPY2RNPY5R | |
| SCHEMBL22117542 | 0.86 | NPY4R (0.47) | OPRM1NPY4RNPY1RNPY2RNPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113544138-A | Mitochondrial targeting peptides | 隐形生物治疗公司 | 2021-10-22 | — | — | CN | disclosed |